Corcept Therapeutics SG&A Expense (TTM) Analysis

Corcept Therapeutics Inc (CORT)

43.93 +0.65 (+1.50%) USD | NASDAQ | Sep 27, 16:00

43.98 +0.05 (+0.11%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2004. Upgrade now.

Date	Value
June 30, 2024	215.62M
March 31, 2024	191.96M
December 31, 2023	184.26M
September 30, 2023	179.43M
June 30, 2023	169.33M
March 31, 2023	163.86M
December 31, 2022	152.85M
September 30, 2022	142.81M
June 30, 2022	138.18M
March 31, 2022	130.40M
December 31, 2021	122.36M
September 30, 2021	115.77M
June 30, 2021	111.76M
March 31, 2021	107.30M
December 31, 2020	105.33M
September 30, 2020	106.76M
June 30, 2020	104.48M
March 31, 2020	103.50M
December 31, 2019	100.36M
September 30, 2019	94.78M
June 30, 2019	91.85M
March 31, 2019	87.24M
December 31, 2018	81.29M
September 30, 2018	76.52M
June 30, 2018	71.69M

Date	Value
March 31, 2018	65.82M
December 31, 2017	62.42M
September 30, 2017	57.38M
June 30, 2017	51.84M
March 31, 2017	49.85M
December 31, 2016	45.24M
September 30, 2016	42.34M
June 30, 2016	40.70M
March 31, 2016	37.93M
December 31, 2015	36.95M
September 30, 2015	36.13M
June 30, 2015	35.94M
March 31, 2015	34.56M
December 31, 2014	34.92M
September 30, 2014	34.39M
June 30, 2014	32.47M
March 31, 2014	32.66M
December 31, 2013	31.24M
September 30, 2013	30.20M
June 30, 2013	28.72M
March 31, 2013	26.31M
December 31, 2012	25.41M
September 30, 2012	22.21M
June 30, 2012	19.73M
March 31, 2012	16.64M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

94.78M

Minimum

Sep 2019

215.62M

Maximum

Jun 2024

137.05M

Average

126.38M

Median

SG&A Expense (TTM) Benchmarks